How does the RM1 ferritin test aim to remove cost barriers for women?

Question

Accepted Answer

Alpro Pharmacy's Initiative Reduces Cost Barriers for Ferritin Screening

Alpro Pharmacy is offering eligible women a ferritin screening for RM1, a significant reduction from the usual RM35 price. This initiative aims to make iron-store assessment more accessible by subsidising RM34 of the screening cost, directly addressing the financial barrier that often prevents women from undergoing necessary health checks. The RM1 price point is specifically designed to remove cost as the primary obstacle to screening, encouraging broader participation within the community.
Subsidising the Cost of Assessment

Through the Me. NO PAUSE initiative, Alpro Pharmacy is absorbing the majority of the cost associated with ferritin testing. By providing the screening for RM1, Alpro is making a direct investment to ensure that financial constraints do not impede women's ability to monitor their iron levels. This substantial subsidy is a key component of Alpro's strategy to improve accessibility and encourage proactive health management among women.
Encouraging Early Detection and Awareness

The RM1 ferritin test is part of a larger effort by Alpro Pharmacy to shift the conversation around women's health, particularly concerning the transition to menopause. By making screening affordable, Alpro hopes to empower women, especially those aged 35 and above experiencing symptoms like persistent tiredness, brain fog, hair loss, or brittle nails, to seek timely assessment. This proactive approach aims to facilitate earlier identification of potential iron deficiencies before they escalate to more serious conditions like iron-deficiency anaemia, which affects approximately one in three Malaysian women of reproductive age.
Pharmacists as Key Facilitators

The Me. NO PAUSE initiative also focuses on empowering community pharmacists. With the subsidised RM1 ferritin checks, pharmacists are better positioned to identify women at risk of iron deficiency, offer immediate counselling based on the results, and guide them towards further medical evaluation if required. This integration of accessible screening with professional pharmacist support aims to translate awareness into tangible health actions for women.

Reading history

Hide →

This history is cleared when the page is closed.

How does the RM1 ferritin test aim to remove cost barriers for women?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

2

0

0

Share with friends